Document is current
Any future updates will be listed below
-
Authors
Kristensen, Anna Kjær https://orcid.org/0000-0002-4976-0794
Frandsen, Clarissa Lima Brown https://orcid.org/0000-0003-0956-9765
Møller, Maria https://orcid.org/0009-0001-9783-4460
Nøhr, Bugge https://orcid.org/0009-0009-9744-4452
Hjalgrim, Henrik https://orcid.org/0000-0002-4436-6798
Viuff, Jakob Hansen https://orcid.org/0000-0002-5370-2589
Hargreave, Marie https://orcid.org/0000-0001-6821-9242
Kjær, Susanne Krüger https://orcid.org/0000-0002-8347-1398
Jensen, Allan https://orcid.org/0000-0001-8124-4880
-
Funding
Funding for this research was provided by:
Danish Cancer Society (R309-A17906)
- License Information
-
More Information
Article History
Received: 8 October 2024
Accepted: 13 May 2025
First Online: 2 June 2025
Declarations
:
: B.N. received grants from Gedeon Richter Nordics AB, IBSA Nordic APS, and Merck KGAA, consulting fees from Ferring Pharmaceuticals A/S, honoraria for lectures from Organon Denmark ApS, and support for meeting attendance from Gedeon Richter Nordics AB. The remaining authors have no conflict of interest to declare.
: The study was approved by the Danish Health Data Board and Statistics Denmark (J.nr. 704645) and the Local Ethical Committees for Copenhagen and Frederiksberg municipalities (J.nr. 01–298/96) and approved and registered in the archive list DCS-DCRC-2100 of the Danish Cancer Institute (J.nr. 2019-DCRC-0020).
